Home      Contact      Sitemap     Deutsch  
 
 
Investor Relations
News
Stock Quotation
Reports
Performance Figures
Annual General Meeting
Corporate Governance
Financial Calendar
Stockholder Structure
Issuing Dates
Presentations
Research
IR Contact Form
IR Contact Person
 
 
Ad-hoc Announcement dated September 3, 2008



aap closed 5% Capital Increase successfully



aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange in the Prime Standard segment, has successfully completed its yesterday announced 5% capital increase. The capital increase was placed in full by an issue of 1,267,357 shares at a price of EUR 2.18 apiece.

Until the registration of the implementation of the capital increase and the listing of the new shares – expected to be effected end of September 2008 – a major shareholder of the company made own shares available by a temporary securities loan for the investors supply.

Subject to the recording of the capital increase in the commercial register the company’s capital will increase by EUR 1,267,357 from the present EUR 25,347,156 to EUR 26,614,513, divided into the same number of registered shares. From the capital increase the company receives more than EUR 2.7, intended to serve the purpose of funding further growth.




For further information, please contact:
aap Implantate AG
Lorenzweg 5
D-12099 Berlin
X
Oliver Bielenstein

Nanette Hüdepohl

Director/CFO

Head of Corporate Communications and Legal Affairs

Tel.: +49 30 750 19 - 140

Tel.: +49 30 75019 - 133

Fax: +49 30 750 19 - 290

Fax: +49 30 75019 - 290

X
WKN 506660, ISIN DE0005066609
Prime Standard/Regulated Market
Traded at all German Stock Exchanges



© 2012 aap Implantate AG


Print this page